Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Hepatitis CChronic Pain
Interventions
DRUG

Alisporivir

ALV 200 mg soft gel capsules administered orally

DRUG

Peginterferon alfa-2a

PEG 180 μg administered via subcutaneous (s.c.) injection once weekly

DRUG

Ribavirin

RBV 400 mg (2 x 200 mg tablets) administered orally twice daily (BID)

Trial Locations (73)

807

Novartis Investigative Site, Kaohsiung City

1070

Novartis Investigative Site, Brussels

2145

Novartis Investigative Site, Westmead

2217

Novartis Investigative Site, Kogarah

2747

Novartis Investigative Site, Kingswood

3000

Novartis Investigative Site, Leuven

3065

Novartis Investigative Site, Fitzroy

3168

Novartis Investigative Site, Clayton

4120

Novartis Investigative Center, Greenslopes

9000

Novartis Investigative Site, Ghent

10002

Novartis Investigative Site, Taipei

10021

Weill Cornell Medical Center, New York

10029

Mount Sinai Medical Center, New York

10032

Columbia University Medical Center, New York

10126

Novartis Investigative Site, Torino

10700

Novartis Investigative Site, Bangkok

10969

Novartis Investigative Site, Berlin

13008

Novartis Investigative Site, Marseille

25123

Novartis Investigative Site, Brescia

27100

Novartis Investigative Site, Pavia

30625

Novartis Investigative Site, Hanover

40138

Novartis Investigative Site, Bologna

40447

Novartis Investigative Site, Taichung

50200

Novartis Investigative Site, Chiang Mai

60590

Novartis Investigative Site, Frankfurt

63104

Saint Louis University, St Louis

66606

Cotton O'Neil Clinical Research, Topeka

75006

Novartis Investigative Site, Paris

76012

The North Texas Research Institute, Arlington

77030

Liver Associates of Texas, Houston

Liver Specialist of Texas, Houston

78215

Alamo Medical Research, San Antonio

79095

Novartis Investigative Site, Freiburg im Breisgau

83301

Novartis Investigative Site, Niaosong Township

90110

Novartis Investigative Site, Songkhla

92037

Scripps Clinic, La Jolla

92101

Sharp Rees-Stealy Medical Group, Inc., San Diego

92105

Research and Education Inc., San Diego

92118

Novartis Investigative Site, Clichy

93003

Island View Gastroenterology Associates, Ventura

94000

Novartis Investigative Site, Créteil

96817

Hawai Medical Center East LLC, Honolulu

110070

Novartis Investigative Site, New Delhi

122001

Novartis Investigative Site, Haryāna

141001

Novartis Investigative Site, Ludhiana

226014

Novartis Investigative Site, Lucknow

400020

Novartis Investigative Site, Mumbai

400036

Novartis Investigative Site, Mumbai

500012

Novartis Investigative Site, Hyderabad - Andhra Pradesh

695607

Novartis Investigative Site, Trivandrum

781006

Novartis Investigative Site, Guwahati

01107

The Office of Dr. Claudia Martorell, Springfield

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

V5Z 1H2

Novartis Investigative Site, Vancouver

M4V 1P7

Novartis Investigative Site, Toronto

04103

Novartis Investigative Site, Leipzig

00133

Novartis Inestigative Site, Roma

15-540

Novartis Investigative Site, Bialystok

91-347

Novartis Investigative Site, Lódz

01 - 201

Novartis Investigative Site, Warsaw

00927

Fundacion de Investigacion de Diego, San Juan

120-752

Novartis Korea Ltd., Seoul

602-739

Novartis Inestigative Center, Pusan

614-735

Novartis Investigative Site, Pusan

738-736

Novartis Investigative Site, Seoul

Unknown

Novartis Investigative Site, Douliu

ROC112

Novartis Investigative Site, Taipei

G12 OYN

Novartis Investigative Site, Glasgow - Scotland

E1 1BB

Novartis Investigative Site, London

SE5 9RS

Novartis Investigative Site, London

SW17 0QT

Novartis Investigative Site, London

W2 1NY

Novartis Investigative Site, London

PL6 8DH

Novartis Investigative Site, Plymouth

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY